Testing airflow limits in asthma flare-ups
Part of Immune system & allergy, Lungs & breathing clinical trials.
This Phase 4 study looks at what causes breathing airways to narrow during asthma worsening, in people with stable, treated asthma. It may help improve how clinicians understand and manage asthma flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently do not smoke, or have smoked less than 10 pack-years in your life
- You’re between 10 and 80 years old
- You have asthma that is stable and already being treated
- Your breathing test is abnormal even after using albuterol: FEV1/FVC is below 70%
- Your FEV1 is below 80% of what’s expected for your age
- You are not pregnant (pregnancy is not allowed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at why airflow is limited in people with moderate-to-severe persistent asthma who are already on stable treatment. It may help researchers better understand what drives breathing trouble and how to target it.
This study looks at how asthma affects air flow and blood flow in your lungs. You may join if you use daily asthma control medicine and your breathing test shows room for improvement even after using a rescue inhaler.
This study tests a new way to treat asthma flares in children and teens (ages 6–18) with mild-to-moderate asthma. It aims to see if a quick-relief anti-inflammatory medicine works better than current treatments to prevent severe attacks.
This trial tests whether stepping up to either a higher dose of inhaled steroid/long-acting bronchodilator or a special fine-particle triple therapy (which includes an extra medication) can improve small-airway health in people whose asthma is still not well controlled on a medium-dose combination.
This study tests a new combination inhaler (fluticasone propionate and albuterol) for people with asthma age 12 and older. It helps see if this inhaler works better than a placebo in controlling asthma symptoms and preventing attacks.
This study tests a new way to improve care for adults with asthma who have had a recent severe attack. It aims to see if better management can prevent future flare-ups.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.